Janet Pope

45.5k total citations · 8 hit papers
512 papers, 19.0k citations indexed

About

Janet Pope is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Janet Pope has authored 512 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 285 papers in Rheumatology, 221 papers in Pathology and Forensic Medicine and 100 papers in Immunology. Recurrent topics in Janet Pope's work include Rheumatoid Arthritis Research and Therapies (199 papers), Systemic Sclerosis and Related Diseases (175 papers) and Systemic Lupus Erythematosus Research (119 papers). Janet Pope is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (199 papers), Systemic Sclerosis and Related Diseases (175 papers) and Systemic Lupus Erythematosus Research (119 papers). Janet Pope collaborates with scholars based in Canada, United States and United Kingdom. Janet Pope's co-authors include Gerd R Burmester, Christopher P. Denton, Murray Baron, Boulos Haraoui, Carter Thorne, Janine Ouimet, Oliver Distler, Dinesh Khanna, Vivian P. Bykerk and Yannick Allanore and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Janet Pope

493 papers receiving 18.5k citations

Hit Papers

Novel treatment strategie... 1997 2026 2006 2016 2017 2015 2015 2013 1997 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Janet Pope 7.9k 7.2k 4.2k 3.1k 2.7k 512 19.0k
Daniel E. Furst 6.1k 0.8× 6.9k 1.0× 3.8k 0.9× 3.8k 1.2× 2.2k 0.8× 382 17.5k
Ulf Müller‐Ladner 5.5k 0.7× 5.0k 0.7× 4.2k 1.0× 2.1k 0.7× 2.0k 0.7× 495 16.9k
Daniel E. Fürst 12.3k 1.6× 5.0k 0.7× 4.6k 1.1× 1.8k 0.6× 1.4k 0.5× 258 22.1k
Dinesh Khanna 4.1k 0.5× 11.2k 1.5× 3.3k 0.8× 7.6k 2.5× 3.3k 1.2× 503 20.2k
John D. Reveille 14.3k 1.8× 4.4k 0.6× 9.0k 2.1× 1.4k 0.5× 1.1k 0.4× 384 21.3k
Deborah Symmons 16.0k 2.0× 3.4k 0.5× 6.9k 1.6× 1.3k 0.4× 1.6k 0.6× 396 27.2k
Cynthia S. Crowson 13.7k 1.7× 2.7k 0.4× 4.3k 1.0× 6.2k 2.0× 733 0.3× 476 28.1k
Beat A. Michel 8.7k 1.1× 2.8k 0.4× 3.3k 0.8× 8.7k 2.9× 855 0.3× 205 20.9k
Jeffrey R. Curtis 11.3k 1.4× 2.9k 0.4× 4.0k 1.0× 1.3k 0.4× 809 0.3× 684 25.1k
Miguel Á. González‐Gay 13.5k 1.7× 2.3k 0.3× 6.3k 1.5× 8.4k 2.8× 875 0.3× 799 25.0k

Countries citing papers authored by Janet Pope

Since Specialization
Citations

This map shows the geographic impact of Janet Pope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Pope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Pope more than expected).

Fields of papers citing papers by Janet Pope

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Pope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Pope. The network helps show where Janet Pope may publish in the future.

Co-authorship network of co-authors of Janet Pope

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Pope. A scholar is included among the top collaborators of Janet Pope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Pope. Janet Pope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Charis F., Yvonne Lee, Orit Schieir, et al.. (2024). Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis. ACR Open Rheumatology. 6(6). 347–355. 2 indexed citations
2.
Solitano, Virginia, Yuhong Yuan, Siddharth Singh, et al.. (2024). Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials. Journal of Autoimmunity. 149. 103331–103331. 12 indexed citations
4.
Jairath, Vipul, Waqqas Afif, Brian Bressler, et al.. (2024). Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies. Journal of the Canadian Association of Gastroenterology. 7(4). 282–289. 2 indexed citations
5.
Matteson, Eric L., Marco Matucci‐Cerinic, Michael Kreuter, et al.. (2023). Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open. 9(3). e003059–e003059. 6 indexed citations
6.
Taylor, Peter C., Arthur Kavanaugh, Peter Nash, et al.. (2023). AB0290 EFFECT OF FILGOTINIB ON PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE PHASE 3 FINCH 1, 2 AND 3 STUDIES. Lirias (KU Leuven). 1326.2–1327. 1 indexed citations
7.
Pope, Janet, et al.. (2022). Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis. Best Practice & Research Clinical Rheumatology. 36(4). 101822–101822. 2 indexed citations
8.
Bergstra, Sytske Anne, Alexandre Sepriano, Andreas Kerschbaumer, et al.. (2022). Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(1). 81–94. 56 indexed citations
9.
Hazlewood, Glen, Jordi Pardo Pardo, Cheryl Barnabé, et al.. (2022). Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs. The Journal of Rheumatology. 49(10). 1092–1099. 12 indexed citations
10.
Kerschbaumer, Andreas, Alexandre Sepriano, Sytske Anne Bergstra, et al.. (2022). Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(1). 95–106. 90 indexed citations
11.
Widdifield, Jessica, Jennifer J. Lee, Carter Thorne, et al.. (2022). Results From the 2020 Canadian Rheumatology Association’s Workforce and Wellness Survey. The Journal of Rheumatology. 49(6). 635–643. 18 indexed citations
12.
Bălănescu, Andra, Gustavo Citera, Virginia Pascual‐Ramos, et al.. (2022). Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial. Annals of the Rheumatic Diseases. 81(11). 1491–1503. 43 indexed citations
13.
Turk, Matthew, et al.. (2021). A meta-analysis of the epidemiology of giant cell arteritis across time and space. Arthritis Research & Therapy. 23(1). 97 indexed citations
14.
Hazlewood, Glen, Adalberto Loyola‐Sánchez, Vivian P. Bykerk, et al.. (2021). Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study. Lara D. Veeken. 61(2). 606–616. 15 indexed citations
15.
Fortin, Paul R., Deborah Da Costa, Carolyn Neville, et al.. (2020). Challenges of Perceived Self‐Management in Lupus. Arthritis Care & Research. 74(7). 1113–1121. 12 indexed citations
16.
Deardon, Rob, Cheryl Barnabé, Vivian P. Bykerk, et al.. (2019). Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis. ACR Open Rheumatology. 1(8). 471–479. 4 indexed citations
17.
Widdifield, Jessica, Sasha Bernatsky, Janet Pope, et al.. (2019). Encounters with Rheumatologists in a Publicly Funded Canadian Healthcare System: A Population-based Study. The Journal of Rheumatology. 47(3). 468–476. 12 indexed citations
18.
Widdifield, Jessica, Michał Abrahamowicz, J. Michael Paterson, et al.. (2018). Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis. The Journal of Rheumatology. 46(5). 467–474. 28 indexed citations
19.
Choi, May Y., Cheryl Barnabé, Claire Barber, et al.. (2018). Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic Review. Arthritis Care & Research. 71(5). 620–628. 12 indexed citations
20.
Nagaraj, Sujay, Cheryl Barnabé, Orit Schieir, et al.. (2017). Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis. Arthritis Care & Research. 70(8). 1245–1250. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026